Read on Twitter
#ESCCongress @MaasAngela presenting on IHD in perimenopause:
So Who is at risk? And why?
Hormones fluctuate over a lifetime in BOTH men &
There are benefits of estrogen in women protecting them but at menopause it changes and more risk factors 
the risk for disease
So Who is at risk? And why?
Hormones fluctuate over a lifetime in BOTH men &There are benefits of estrogen in women protecting them but at menopause it changes and more risk factors the risk for disease
@MaasAngela #ESCCongress
insulin resistance
inflammation
adverse cardiometabolic risk profile
All seen in menopause, increasing the risk of CVD in
insulin resistanceinflammation adverse cardiometabolic risk profileAll seen in menopause, increasing the risk of CVD in
#ESCCongress @MaasAngela
we know a lot about obstructive CAD
WE do not know enough about Coronary Vasomotor disorders or Microvascular disorders (INOCA/MINOCA)- these affect
Our knowledge about assessment & treatment of non obstructive CAD remains limited
@Drroxmehran
we know a lot about obstructive CADWE do not know enough about Coronary Vasomotor disorders or Microvascular disorders (INOCA/MINOCA)- these affect Our knowledge about assessment & treatment of non obstructive CAD remains limited
@Drroxmehran
#ESCCongress @MaasAngela shows that women have different patters of IHD
Women with more diffuse disease
Men with more focal lesions
Prognosis not better for
Women with more diffuse diseaseMen with more focal lesionsPrognosis not better for
#ESCCongress @MaasAngela
Understand the sex-specific risk factors in women like preeclampsia; should be part of our history taking
#sexdifferences @ASCVDRiskEnhancers
Understand the sex-specific risk factors in women like preeclampsia; should be part of our history taking
#sexdifferences @ASCVDRiskEnhancers
